Our Blog

REFRAMING THE EVIDENCE Disease-Modifying Treatments in Alzheimer’s: A New Era of Clinical Possibility

The Cochrane Collaboration review of 17 randomised controlled trials involving 20,342 participants has contributed to recent debate about anti-amyloid therapies in Alzheimer’s disease. However, it is important […]

Diet, Genetics and Brain Health: What a New Study Reveals About Alzheimer’s Risk

Emerging research continues to reshape how we understand the relationship between diet and cognitive health. A recent study led by Jakob Norgren and colleagues offers a more […]

How Coffee May Support Mental Health: Insights from Dr Tom MacLaren

Dr Tom MacLaren, consultant psychiatrist at Re:Cognition Health, spoke with Medical News Today about a recent large observational study exploring the relationship between coffee consumption and mental […]

Re:Cognition Health Shortlisted for HealthInvestor 2026 Award: Driving Excellence in Diagnostics

Re:Cognition Health is delighted to announce that we have been shortlisted for the HealthInvestor 2026 Award – Diagnostics Provider of the Year. This nomination reflects our ongoing […]

How New Experiences Support Brain Health

Looking after our brains is just as important as looking after our bodies. At Re:Cognition Health, we often emphasise that keeping the mind active is key to […]

A Breakthrough in Treating Degenerative Brain Diseases

In her compelling TEDx Athens Salon talk, delivered as part of the TEDx Global Idea Search, Dr Emer MacSweeney, CEO and Consultant Neuroradiologist at Re:Cognition Health, presented […]

Prenatal Paracetamol and Neurodevelopment: Why This New Review Matters

Recent years have seen a surge in headlines suggesting that taking paracetamol (also known as acetaminophen or Tylenol) during pregnancy may increase the risk of autism, ADHD […]

The Hidden Symptoms of ADHD: What We Don’t Talk About Enough

Public understanding of ADHD has grown significantly in recent years. We now know that ADHD is not limited to disruptive behaviour in childhood  and that it affects […]

Blue Monday: Seasonal Slump or Mental Health Myth?

Dr Dimitrios Paschos, Consultant Psychiatrist at Re:Cognition Health, was featured in an article on Medical News Today exploring the reality behind “Blue Monday” – the so-called most […]

Alzheimer’s Fingerprick Tests: Why Blood-Based Biomarker Trials Matter

Early diagnosis has long been one of the greatest challenges in Alzheimer’s disease. For decades, clinicians have been forced to rely on expensive brain scans, invasive lumbar […]